Untill September 2022 The Netherlands Pharmacovigilance Centre Lareb received 118 reports of adverse events after the monkeypox vaccination (Imvanex). The most reported reactions w ...
Read more
16 NOV
Heavy menstrual bleeding in product information Pfizer and Moderna vaccines
The EMA recommended to add heavy menstrual bleeding to the product information of the COVID-19 vaccines of Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax). The Netherlands Pharm ...
Read more
28 OCT
Allergic reactions after COVID-19 vaccination
Until June 2022 The Netherlands Pharmacovigilance Centre Lareb received almost 4000 reports of symptoms possibly related to acute allergic reactions based on estimated 36 million g ...
Read more
14 OCT
Dimethyl fumarate and alopecia
The Netherlands Pharmacovigilance Centre Lareb has received 92 cases about alopecia associated with the use of dimethyl fumarate. Alopecia is not described in the Dutch Summary of ...
Read more
09 OCT
Anastrozole and depressed mood
The Netherlands Pharmacovigilance Centre Lareb received 14 reports of depressed mood associated with the use of anastrozole (Arimedex®). In the Summary of Product Characteristics o ...
Read more
18 SEP
Patient organizations can help enable effective communication of adverse drug reactions
To improve therapeutic decision making, it is crucial that information regarding adverse drug reactions reaches patients. One possible avenue is to collaborate with patient organiz ...
